CVS Health Corporation (CVS)

CVS Health Stock Forecast

Stock Price Forecast

The 17 analysts that cover CVS Health stock have a consensus rating of "Strong Buy" and an average price target of $78.29, which forecasts a 9.07% increase in the stock price over the next year. The lowest target is $65 and the highest is $87.

Price Target: $78.29 (+9.07%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$65	$78.29	$80	$87
Change	-9.45%	+9.07%	+11.45%	+21.20%

Analyst Ratings

The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	5	3	4	4	5	5
Buy	8	8	8	8	11	11
Hold	3	3	3	3	0	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	14	15	15	16	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lance Wilkes Bernstein	Bernstein	Hold Maintains $72 → $77	Hold	Maintains	$72 → $77	+7.27%	Sep 5, 2025
Andrew Mok Barclays	Barclays	Buy Maintains $80 → $87	Buy	Maintains	$80 → $87	+21.20%	Sep 4, 2025
Sarah James Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $78	Buy	Reiterates	$78	+8.67%	Aug 26, 2025
Kevin Caliendo UBS	UBS	Hold → Strong Buy Upgrades $67 → $79	Hold → Strong Buy	Upgrades	$67 → $79	+10.06%	Aug 18, 2025
Michael Ha Baird	Baird	Hold → Buy Upgrades $71 → $82	Hold → Buy	Upgrades	$71 → $82	+14.24%	Aug 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

397.12B

Increased by 7.14%

from 370.66B

Revenue Next Year

414.58B

Increased by 4.40%

from 397.12B

EPS This Year

6.42

Increased by 75.36%

from 3.66

EPS Next Year

7.22

Increased by 12.46%

from 6.42

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	267.91B	290.91B	321.63B	356.62B	370.66B	397.12B	414.58B
Revenue Growth	4.75%	8.59%	10.56%	10.88%	3.94%	7.14%	4.40%
EPS	5.46	6.02	3.26	6.47	3.66	6.42	7.22
EPS Growth	7.54%	10.19%	-45.85%	98.47%	-43.43%	75.36%	12.46%
Forward PE	-	-	-	-	-	11.18	9.94
No. Analysts	-	-	-	-	-	30	29

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	417.2B	451.6B
Avg	397.1B	414.6B
Low	382.8B	384.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.6%	13.7%
Avg	7.1%	4.4%
Low	3.3%	-3.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	6.83	8.19
Avg	6.42	7.22
Low	5.91	6.36

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	86.5%	27.6%
Avg	75.4%	12.5%
Low	61.5%	-0.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.